Overview

Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

This study compares aripiprazole once-monthly injection to standard of care oral antipsychotic medication in non-adherent outpatients with schizophrenia to see which treatment helps people take their medicine more regularly and have more positive outcomes. It is hypothesized that non-adherent schizophrenia outpatients receiving aripiprazole once-monthly will be more likely to respond and have lower symptom severity over 3 months of treatment than those receiving standard of care oral antipsychotics.

Phase:

Phase 4

Details

Lead Sponsor:

Matt Byerly

Collaborator:

Otsuka America Pharmaceutical

Treatments:

Antipsychotic Agents
Aripiprazole
Lurasidone Hydrochloride
Olanzapine
Quetiapine Fumarate
Risperidone
Ziprasidone